The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Drug Discovery: A Historical Perspective
Abstract
Driven by chemistry but increasingly guided by pharmacology and the clinical sciences, drug research has contributed more to the progress of medicine during the past century than any other scientific factor. The advent of molecular biology and, in particular, of genomic sciences is having a deep impact on drug discovery. Recombinant proteins and monoclonal antibodies have greatly enriched our therapeutic armamentarium. Genome sciences, combined with bioinformatic tools, allow us to dissect the genetic basis of multifactorial diseases and to determine the most suitable points of attack for future medicines, thereby increasing the number of treatment options. The dramatic increase in the complexity of drug research is enforcing changes in the institutional basis of this interdisciplinary endeavor. The biotech industry is establishing itself as the discovery arm of the pharmaceutical industry. In bridging the gap between academia and large pharmaceutical companies, the biotech firms have been effective instruments of technology transfer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Besides theorem proving, many real-world problems deal with unbounded search spaces, such as program synthesis [Gulwani et al. 2017], drug discovery [Drews 2000], chemical synthesis [Segler et al. 2018], computer-aided design [Haigh 1985], combinatorial optimization [Bengio et al. 2021], and more.”
From On the Opportunities and Risks of Foundation Models (2021) · cites this paper as Drews 2000
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Continuous cultures of fused cells secreting antibody of predefined specificity
KÖHLER, G., & MILSTEIN, C. (1975) · Nature · doi:10.1038/256495a0 · Cited by 17,229
A Hot Spot of Binding Energy in a Hormone-Receptor Interface
Clackson, T., & Wells, J. A. (1995) · Science · doi:10.1126/science.7529940 · Cited by 1,983
Small Molecule Inhibitor of Mitotic Spindle Bipolarity Identified in a Phenotype-Based Screen
Mayer, T. U., Kapoor, T. M., Haggarty, S. J., King, R. W., Schreiber, S. L., & Mitchison, T. J. (1999) · Science · doi:10.1126/science.286.5441.971 · Cited by 1,727
Selective antagonists of benzodiazepines
Hunkeler, W., Möhler, H., Pieri, L., Polc, P., Bonetti, E. P., Cumin, R., Schaffner, R., & Haefely, W. (1981) · Nature · doi:10.1038/290514a0 · Cited by 1,232
Generation of a Large Combinatorial Library of the Immunoglobulin Repertoire in Phage Lambda
Huse, W. D., Sastry, L., Iverson, S. A., Kang, A. S., Alting-Mees, M., Burton, D. R., Benkovic, S. J., & Lerner, R. A. (1989) · Science · doi:10.1126/science.2531466 · Cited by 805
Pharmacological Rescue of Mutant p53 Conformation and Function
Foster, B. A., Coffey, H. A., Morin, M. J., & Rastinejad, F. (1999) · Science · doi:10.1126/science.286.5449.2507 · Cited by 799
Carbonic anhydrase. Its preparation and properties
Meldrum, N. U., & Roughton, F. J. W. (1933) · The Journal of Physiology · doi:10.1113/jphysiol.1933.sp003077 · Cited by 649
A humanized antibody that binds to the interleukin 2 receptor.
Queen, C., Schneider, W. P., Selick, H. E., Payne, P. W., Landolfi, N. F., Duncan, J. F., Avdalovic, N. M., Levitt, M., Junghans, R. P., & Waldmann, T. A. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.24.10029 · Cited by 627
Kuivenhoven, J. A., Jukema, J. W., Zwinderman, A. H., de Knijff, P., McPherson, R., Bruschke, A. V. G., Lie, K. I., & Kastelein, J. J. P. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801083380203 · Cited by 625
Affinity-Driven Peptide Selection of an NFAT Inhibitor More Selective Than Cyclosporin A
Aramburu, J., Yaffe, M. B., López-Rodrı́guez, C., Cantley, L. C., Hogan, P. G., & Rao, A. (1999) · Science · doi:10.1126/science.285.5436.2129 · Cited by 613
Penicillin as a Chemotherapeutic Agent
Chain, E., Florey, H. W., Gardner, A. D., Heatley, N. G., Jennings, M. A., Orr-Ewing, J., & Sanders, A. G. (1940) · The Lancet · doi:10.1016/s0140-6736(01)08728-1 · Cited by 603
Langley, J. N. (1905) · The Journal of Physiology · doi:10.1113/jphysiol.1905.sp001128 · Cited by 602
Antibody phage display technology and its applications
Hoogenboom, H. R., de Bruı̈ne, A. P., Hufton, S. E., Hoet, R. M., Arends, J.-W., & Roovers, R. C. (1998) · Immunotechnology · doi:10.1016/s1380-2933(98)00007-4 · Cited by 512
Structural genomics: beyond the Human Genome Project
Burley, S. K., Almo, S. C., Bonanno, J. B., Capel, M., Chance, M. R., Gaasterland, T., Lin, D., Šali, A., Studier, F. W., & Swaminathan, S. (1999) · Nature Genetics · doi:10.1038/13783 · Cited by 379
THE MAMMALIAN LOW-DENSITY LIPOPROTEIN RECEPTOR FAMILY
Hussain, M. M., Strickland, D. K., & Bakillah, A. (1999) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.19.1.141 · Cited by 377
Discovery, biochemistry and biology of lovastatin
Alberts, A. W. (1988) · The American Journal of Cardiology · doi:10.1016/0002-9149(88)90002-1 · Cited by 358
Evolution and the genetics of populations. Vol. 1. Genetic and biométrie foundations.
Wright, S. M. (1968) · Cited by 351
Phage-display technology – finding a needle in a vast molecular haystack
Rodi, D. J., & Makowski, L. (1999) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(99)80016-0 · Cited by 208
Predicting ligand binding to proteins by affinity fingerprinting
Kauvar, L. M., Higgins, D. L., Villar, H. O., Sportsman, J. R., Engqvist-Goldstein, Å., Bukar, R., Bauer, K. E., Dilley, H., & Rocke, D. M. (1995) · Chemistry & Biology · doi:10.1016/1074-5521(95)90283-x · Cited by 208
Population statistics of protein structures: lessons from structural classifications
Brenner, S. E., Chothia, C., & Hubbard, T. J. (1997) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(97)80054-1 · Cited by 163
Lahana, R. (1999) · Drug Discovery Today · doi:10.1016/s1359-6446(99)01393-8 · Cited by 160
Sertuerner (1817) · Annalen der Physik · doi:10.1002/andp.18170550104 · Cited by 148
Signaling antibodies in cancer therapy
Cragg, M. S., French, R. R., & Glennie, M. J. (1999) · Current Opinion in Immunology · doi:10.1016/s0952-7915(99)00010-2 · Cited by 119
The Molecular Basis for Growth Hormone–Receptor Interactions
Wells, J. A., Cunningham, B. C., Fuh, G., Lowman, H. B., Ultsch, M. H., deVos, A. M., Bass, S., & Mulkerrin, M. G. (1993) · Elsevier eBooks · doi:10.1016/b978-0-12-571148-7.50013-0 · Cited by 116
In Quest of Tomorrow’s Medicines
Drews, J. (1999) · Springer eBooks · doi:10.1007/978-1-4612-1404-5 · Cited by 100
Self-citationInnovation Deficit in the Pharmaceutical Industry
Drews, J., & Ryser, S. (1996) · Drug Information Journal · doi:10.1177/009286159603000113 · Cited by 82
Self-citationBioactive Diversity and Screening Library Selection via Affinity Fingerprinting
Dixon, S. L., & Villar, H. O. (1998) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci980105+ · Cited by 68
Winter, G. P., & Harris, W. J. (1993) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(93)90197-r · Cited by 56
Innovation deficit revisited: reflections on the productivity of pharmaceutical R&D
Drews, J. (1998) · Drug Discovery Today · doi:10.1016/s1359-6446(98)01252-5 · Cited by 55
Self-citationLeptin concentrations do not predict weight gain: The Mexico City Diabetes Study
Haffner, S., Mykkänen, L., Gonzalez, C., & D, M. P. S. M. (1998) · International Journal of Obesity · doi:10.1038/sj.ijo.0800619 · Cited by 41
Maxwell, R. A., & Eckhardt, S. B. (1990) · Humana Press eBooks · doi:10.1007/978-1-4612-0469-5 · Cited by 38
Chouchane, L., Sfar, I., Bousaffara, R., Kamel, A. E., Sfar, M. T., & Ismaïl, A. (1999) · International Archives of Allergy and Immunology · doi:10.1159/000024219 · Cited by 30
Drews, J., & Ryser, S. (1997) · Nature Biotechnology · doi:10.1038/nbt1297-1350 · Cited by 29
Self-citationDiabetes: from phenotypes to genotypes.
Guillausseau, P.-J., Tielmans, D., Virally, M., & Assayag, M. (1997) · PubMed · Cited by 19
Buske, C., Feuring‐Buske, M., Unterhalt, M., & Hiddemann, W. (1999) · European Journal of Cancer · doi:10.1016/s0959-8049(98)00420-1 · Cited by 17
Macromolecular crystallography with a third-generation synchrotron source
Lindley, P. F. (1999) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444999008288 · Cited by 9
Cited by
Initial sequencing and analysis of the human genome
International Human Genome Sequencing Consortium, Whitehead Institute for Biomedical Research, C. F. G. R., Lander, E. S., Linton, L. M., Birren, B., Nusbaum, C., Zody, M. C., Baldwin, J., Devon, K., Dewar, K., et al. (2001) · Nature · doi:10.1038/35057062 · Cited by 24,216
Drug-like properties and the causes of poor solubility and poor permeability
Lipinski, C. A. (2000) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/s1056-8719(00)00107-6 · Cited by 3,734
Hopkins, A. L., & Groom, C. R. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd892 · Cited by 3,305
High-Resolution Crystal Structure of an Engineered Human β 2 -Adrenergic G Protein–Coupled Receptor
Cherezov, V., Rosenbaum, D. M., Hanson, M. A., Rasmussen, S. G. F., Thian, F. S., Kobilka, T. S., Choi, H.-J., Kuhn, P., Weis, W. I., Kobilka, B. K., et al. (2007) · Science · doi:10.1126/science.1150577 · Cited by 3,264
On the Opportunities and Risks of Foundation Models
Bommasani, R., Hudson, D. A., Adeli, E., Altman, R., Arora, S., von Arx, S., Bernstein, M. S., Bohg, J., Bosselut, A., Brunskill, E., et al. (2021) · arXiv · doi:10.48550/arxiv.2108.07258 · Cited by 2,676
Metadata
- Authors
- Drews, J.
- Venue
- Science
- Published
- 2000-03-17
- Volume
- 287
- Issue
- 5460
- Pages
- 1960-1964
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1995089537
- Cited by
- 2,760
- References
- 36
- FWCI
- 87.71
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.